Clinical Trial Update: Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing adjuvant capecitabine to a gemcitabine plus cisplatin regimen in resected extrahepatic cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Asan Medical Center | Conditions: Cholangiocarcinoma, Biliary Tract Cancer | Phase 2 | Status: COMPLETED